OBJECTIVES: To correlate MR findings with pathology in steatotic FNHs and to compare the MR findings with those of other fatty tumours developed on noncirrhotic liver in a consecutive series of resected lesions. METHODS: Our population included resected FNH with intralesional steatosis (n = 25) and other resected fatty tumours selected as controls (hepatocellular adenomas and angiomyolipomas, n = 34). Lesions were classified into three groups: those with typical FNH without (group 1) or with (group 2) fat on MR and those with atypical lesions (group 3). In group 3, diagnostic criteria for other fatty tumours were applied. RESULTS: There were 9 lesions in group 1 (15.3 %), 4 in group 2 (16.8 %) and 46 in group 3 (77.9 %). Group 3 contained 12 FNHs (26 %) and all the other fatty tumours. In group 3, the association of lesion homogeneity, signal intensity similar to or slightly different from adjacent liver on in-phase T1- and T2-weighted sequences, and strong arterial enhancement was observed in 7/12 (58 %) of steatotic FNHs and 3/34 (9 %) of other tumours. CONCLUSION: On MR, fat within a typical FNH should not reduce the diagnostic confidence. We recommend further investigations including liver biopsy if necessary when fatty tumours exhibit atypical MR findings.
OBJECTIVES: To correlate MR findings with pathology in steatotic FNHs and to compare the MR findings with those of other fatty tumours developed on noncirrhotic liver in a consecutive series of resected lesions. METHODS: Our population included resected FNH with intralesional steatosis (n = 25) and other resected fatty tumours selected as controls (hepatocellular adenomas and angiomyolipomas, n = 34). Lesions were classified into three groups: those with typical FNH without (group 1) or with (group 2) fat on MR and those with atypical lesions (group 3). In group 3, diagnostic criteria for other fatty tumours were applied. RESULTS: There were 9 lesions in group 1 (15.3 %), 4 in group 2 (16.8 %) and 46 in group 3 (77.9 %). Group 3 contained 12 FNHs (26 %) and all the other fatty tumours. In group 3, the association of lesion homogeneity, signal intensity similar to or slightly different from adjacent liver on in-phase T1- and T2-weighted sequences, and strong arterial enhancement was observed in 7/12 (58 %) of steatotic FNHs and 3/34 (9 %) of other tumours. CONCLUSION: On MR, fat within a typical FNH should not reduce the diagnostic confidence. We recommend further investigations including liver biopsy if necessary when fatty tumours exhibit atypical MR findings.
Authors: P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi Journal: J Hepatol Date: 2007-01-02 Impact factor: 25.083
Authors: D Mathieu; M Paret; A E Mahfouz; F Caseiro-Alves; J Tran Van Nhieu; M C Anglade; A Rahmouni; N Vasile Journal: Abdom Imaging Date: 1997 Jul-Aug
Authors: A Weimann; B Ringe; J Klempnauer; P Lamesch; K F Gratz; M Prokop; H Maschek; G Tusch; R Pichlmayr Journal: World J Surg Date: 1997 Nov-Dec Impact factor: 3.352
Authors: L B Eisenberg; D M Warshauer; J T Woosley; W G Cance; H Bunzendahl; R C Semelka Journal: J Comput Assist Tomogr Date: 1995 May-Jun Impact factor: 1.826
Authors: Maxime Ronot; Sara Di Renzo; Bettina Gregoli; Rafael Duran; Laurent Castera; Bernard E Van Beers; Valérie Vilgrain Journal: Eur Radiol Date: 2014-09-19 Impact factor: 5.315
Authors: Cheng Fang; Sudha A Anupindi; Susan J Back; Doris Franke; Thomas G Green; Zoltan Harkanyi; Jörg Jüngert; Jeannie K Kwon; Harriet J Paltiel; Judy H Squires; Vassil N Zefov; M Beth McCarville Journal: Pediatr Radiol Date: 2021-05-12